Tracking Results of Ablations to Combat AF Registry Generation 2

Study Summary

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Conditions

Atrial Fibrillation

Interventions / Drugs

Open Concomitant Surgical Ablation Procedures Hybrid (Convergent) Ablation Procedures AtriCure Hybrid Totally Thoracoscopic Ablation Procedures AtriCure LAA Exclusion Procedures

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment10000 participants

Primary Completion—

Lead SponsorAtriCure, Inc.

Data Retrieved2026-04-11 02:55:07.545203+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.